News : Agathos Biologics

April 25, 2024

Agathos Biologics to present data on AE1-BHK cell line for viral vector production

Company to show production of multiple serotypes of recombinant adeno-associated viral (rAAV) vectors and rAAV production in suspension-adapted cell line AE1-BHK-SMorphology of adherent AE1-BHK (A) and suspension AE1-BHK-S (B) cells at 40X magnificationAgathos Biologics, a genetic medicine biotechnology company, will present data at the 27th Annual Meeting of the American…

March 6, 2024

Agathos Biologics launches recombinant adeno-associated virus production service using novel AE1-BHK cell line

Agathos Biologics, a leading biotechnology company in genetic medicine, announced today the launch of its recombinant adeno-associated virus (rAAV) production service using the company’s novel proprietary cell line, AE1-BHK.

September 27, 2023

Agathos Biologics receives $300,000 from the 2023 North Dakota Bioscience Innovation Grant Program

Agathos Biologics, a biotechnology company developing transformational science within a strong ethical and moral framework, today announced the company has been awarded $300,000 from the 2023 North Dakota Department of Agriculture Bioscience Innovation Grant (BIG) Program.

May 3, 2023

Agathos Biologics to present data on cell lines for viral vector production

Agathos Biologics will present data at the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) on the Agathos BHK-[wt E1] and GH329 cell lines for producing recombinant adeno-associated virus (rAAV).

April 12, 2023

Agathos Biologics launches analytical services

With a focus on high-content imaging and digital PCR, Agathos scientists use state-of-the-art technology to deliver unparalleled accuracy and reliability in nucleic acid quantification and cell analysis.

April 21, 2022

Mark Voigt advances Good Science as Director, Business Development and Operations

Voigt's responsibilities include managing laboratory operations and evaluating technology and market opportunities.

February 23, 2022

Agathos expands laboratory space to support genetic medicine and biomanufacturing development

Agathos Biologics expands its laboratory and office space, bringing its total to 10,000 square feet of usable space.

August 30, 2021

Agathos Biologics receives $900,000 from the North Dakota Bioscience Innovation Grant Program

Agathos Biologics, a biotechnology company developing transformational science within a strong ethical and moral framework, today announced the company has been awarded $900,000 from the North Dakota Department of Agriculture Bioscience Innovation Grant (BIG) Program.

August 26, 2021

Agathos publishes white paper in response to current events: The culture of our company need not, and will not, be political.

As we seek to build Agathos Biologics, it’s important to state our mission, values and strategy. We will look for opportunities to refine and further communicate in these areas, and one way to do this is to respond to relevant current events.

July 19, 2021

Agathos Biologics Sponsors Fargo AirSho

Navy Blue Angels and the F-16 Viper Demo Team will highlight the list of over 17 performers